title: Assessment of long-term outcomes of hepatitis C virus infection in a cohort of patients with acute hepatitis in 1971-1975: results of a pilot study.
abstract: BACKGROUND
  To examine the long-term effects of hepatitis C virus (HCV) infection in a cohort of patients admitted to Fairfield Hospital with hepatitis from 1971 to 1975. The availability of stored sera from this time enabled testing to identify those who were anti-HCV positive on admission.
  
  
  METHODS
  Sixteen per cent (n = 230) of the cohort tested positive for HCV antibody (anti-HCV). The 'unexposed' group was selected from those who were anti-HCV negative. Systematic approaches were used to locate the cohort and health outcomes assessed by a study specific questionnaire and clinical review with repeat serology and liver function tests.
  
  
  RESULTS
  Complete follow up has been achieved on a subset of 35 HCV-seropositive and 70 seronegative individuals. The seropositive group was significantly more likely to have given a history of injecting drug use, the presumed route of infection. The seropositive group was also more likely to have elevated serum alanine aminotransferase levels, but only two (6%) were known to have progressed to cirrhosis.
  
  
  CONCLUSIONS
  The anti-HCV-positive individuals followed up to date are at increased risk of liver-related pathology, but few had progressed to cirrhotic liver disease. This differs from findings of transfusion-related studies and suggests, within the limitations of the study, that the natural history of community acquired HCV may be more benign.
authors: Epidemiology and Social Research Unit, The Macfarlane Burnet Centre for Medical Research, Fairfield, Victoria, Australia. rodger@mbcmr.unimelb.edu.au
authors: A J
authors: AJ
authors: Rodger
authors: J A
authors: JA
authors: Thomson
authors: S C
authors: SC
authors: Thompson
authors: D
authors: D
authors: Jolley
authors: A M
authors: AM
authors: Mijch
authors: A
authors: A
authors: Lanigan
authors: N
authors: N
authors: Crofts
mesh_terms: D000208:Acute Disease; D000328:Adult; D015331:Cohort Studies; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000821:virology; D005260:Female; D005500:Follow-Up Studies; D018937:Hepatitis C Antibodies / Q000097:blood; D019698:Hepatitis C, Chronic / Q000453:epidemiology*; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D010865:Pilot Projects; D012307:Risk Factors; D013997:Time Factors
chemical_list: D018937:Hepatitis C Antibodies